Clinical trial for Infertility
Official title Hyaluronic Acid-enriched Transfer Medium in Single Blastocyst Transfer
ClinicalTrials.gov ID: NCT06492785
What this study is testing
What is High Hyaluronic Acid concentrations (0.5 mg/ml)?
High Hyaluronic Acid concentrations (0.5 mg/ml) is an investigational medicine, being studied as a potential treatment for infertility.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to compare the live birth rates of high concentration of Hyaluronic Acid (0.5 mg/ml) transfer medium (EmbryoGlue®) to those containing low Hyaluronic Acid concentrations (0.125 mg/ml) (G2 medium) in women undergoing single fresh and frozen blastocyst transfer.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- All cycles with single blastocyst transfer will be considered eligible
- Both fresh and cryopreserved embryo transfer cycles utilizing autologous oocytes
- No age restriction will be applied
- Informed consent was signed
You likely can't join if
- Uterine anatomic anomalies
- Women with untreated hydrosalpines
- Once couples have been enrolled in the trial, subsequent cycles will not be incorporated.
The study team makes the final eligibility decision.
Where it is enrolling
- Xi'an, Shaanxi, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Xi'an, Shaanxi, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.